FDA Inspection 707872 — Boehringer Ingelheim Roxane, Inc.
The FDA completed an inspection of Boehringer Ingelheim Roxane, Inc. on Jan 7, 2011 in Danbury, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 7, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Danbury, CT (United States)